Bavaria’s AMSilk raises €52M to scale production of silk-based biomaterials
Bavaria-based AMSilk, a company specialised in advanced biomaterials made from silk-based proteins, has secured €52M (€30M in equity, and €22M in convertible bonds) in a funding round led by existing investor ATHOS (AT Newtec).